209 avsnitt
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education cancerGRACE
-
- Hälsa och motion
In this podcast series, the Global Resource for Advancing Cancer Education (GRACE) works to bring professionals together with patients and caregivers to work in partnership.
We interview patients, advocates and healthcare professionals to provide the most updated information for our community and to highlight important issues facing those dealing with a cancer diagnosis.
For more information visit www.cancerGRACE.org. To join the conversation, visit https://cancergrace.org/forums
-
Q&A: Is my Clinical Trial Affecting my Body's Reaction to the Covid-19 Vaccine?
Drs. Goodman, Phillips, Taneja, and Rajeeve discuss how to navigate treatment and Covid vaccination.
-
Bispecific Antibodies in Myeloma: Approvals and Clinical Trials
Dr. Sridevi Rajeeve discusses current FDA approved bispecific antibodies and ones coming from clinical trials.
-
Curative Strategies for Patients with Smoldering Multiple Myeloma
Dr. Alankrita Taneja examines data from the CESAR trial, and discusses curative strategies for Smoldering Multiple Myeloma.
-
Management of Bispecific Antibodies Side Effects
Dr. Sridevi Rajeeve discusses possible side effects from bispecific antibodies, and how to manage them.
-
Teclistamab, Talquetamab, and Elranatamab: Response Rates and Data
Dr. Sridevi Rajeeve discusses the unprecedented response rates in patients treated with teclistamab, talquetamab, and elranatamab, as well as their clinical trial data.
-
Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma
Dr. Tycel Phillips examines the efficacy of two medications against diffuse large b-cell lymphoma (DLBCL)